GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda) are licensed specifically for weight management, while semaglutide (Ozempic) is licensed only for type 2 diabetes treatment
These presentations are nonspecific, so clinicians interpret findings alongside thyroid function, renal status, and nutritional markers
ease Prescription medication to relieve nausea and upset stomach
Nausea, vomiting, and diarrhoeareported by a substantial proportion of patients, especially during treatment initiationresult in the loss of not only water but also essential electrolytes, particularly sodium, potassium, and chloride
Side effect tolerance Temporary digestive symptoms can occur as the body adjusts to treatment
As can be expected in the midst of an obesity epidemic, sales are rocketing